Buat profil saya
Dikutip oleh
Semua | Sejak 2019 | |
---|---|---|
Kutipan | 13828 | 7481 |
indeks-h | 64 | 50 |
indeks-i10 | 204 | 188 |
Akses publik
Lihat semua54 artikel
47 artikel
tersedia
tidak tersedia
Berdasarkan pada mandat pendanaan
Pengarang bersama
- Kaushik ThankiDirector, Early-Stage Formulation Process Development, BioNTech SEEmail yang diverifikasi di biontech.de
- Ashish Kumar AgrawalAssociate Professor, Department of Pharmaceutical Engineering & Technology, IIT (BHU), VaranasiEmail yang diverifikasi di iitbhu.ac.in
- Amit K. Jain, Ph.DSenior Manager, Emergent BiosolutionsEmail yang diverifikasi di ebsi.com
- Uttam Chand BanerjeeNational Institute of Pharmaceutical Education and Research, NIPER, S.A.S. Nagar, Mohali, IndiaEmail yang diverifikasi di niper.ac.in
- Chandraiah GoduguNational Institute of Pharmaceutical Education and Research (NIPER) HyderabadEmail yang diverifikasi di niperhyd.ac.in
- Abhay T. SangamwarNational Institute of Pharmaceutical Education and Research (NIPER), MohaliEmail yang diverifikasi di niper.ac.in
- Himanshu GuptaFDA, Silver Spring, MD, USAEmail yang diverifikasi di opubs.com
- Rahul P. GangwalDr. Reddy's Laboratories LtdEmail yang diverifikasi di drreddys.com
- Sunil KumarSejong UniversityEmail yang diverifikasi di sejong.ac.kr
- Anant Narayan Bhatt, Ph. D.Sr. Scientist, Institute of Nuclear Medicine and Allied SciencesEmail yang diverifikasi di inmas.drdo.in
- Prateek DaniDr. Reddy's Laboratories Ltd., HyderabadEmail yang diverifikasi di drreddys.com
- Kailas Khomane, Ph.D.Dr.Reddy's Laboratories Ltd; NIPER-SAS NagarEmail yang diverifikasi di drreddys.com
- Prof Dr Rakesh Kumar SharmaFormer Pro-Chancellor, SGT University, Gurugram, Former VC, SIMATS and Director (Retd.), DRDO-DFRL
- Sunil MahorSerum Institute of India
- Atul PathakkKeros Therapeutics
- Kamal Kumar UpadhyayIntas Pharmaceutical